Gene Dmel\hb
| General Information | ||||
|---|---|---|---|---|
| Symbol | Dmel\hb | Species | D. melanogaster | |
| Name | hunchback | Annotation symbol | CG9786 | |
| Feature type | protein_coding_gene | FlyBase ID | FBgn0001180 | |
| Created / Updated | 2003-12-01/2003-12-01 | |||
| Genomic Location | ||||
| Chromosome (arm) | 3R | Recombination map | 3-48 | |
| Cytogenetic map | 85A5-85A5 | Sequence location | 3R:4,517,038..4,523,540 [-] | |
| Map ( GBrowse ) |
| |||
Summary Information
| ||||
|
Automatically generated summary
See sections below for more information | The gene hunchback is referred to in FlyBase by the symbol hb (CG9786, FBgn0001180). It has the cytological map location 85A5. Its sequence location is 3R:4517038..4523540. Its molecular function is described as: DNA binding; transcription activator activity; specific RNA polymerase II transcription factor activity; zinc ion binding. It is involved in the biological processes described with 19 unique terms, many of which group under: anatomical structure development; anterior/posterior axis specification; tripartite regional subdivision; embryonic pattern specification; regulation of biological process; regulation of developmental process; axis specification; regulation of metabolic process; open tracheal system development; central nervous system development. 119 alleles are reported. The phenotypes of these alleles are annotated with 74 unique terms, many of which group under: thoracic segment; organ system; embryonic segment; cephalopharyngeal skeleton; embryonic nervous system; embryonic abdomen; nervous system; embryonic neuron; extended germ band embryo; embryonic head. It has 2 annotated transcripts and 2 annotated polypeptides. | |||
| External Summaries | ||||
Phenotypic Description from the Red Book (Lindsley & Zimm 1992)
| ||||
| Gene/Allele symbols may differ from current usage | hb: hunchback
Homozygotes for null alleles of hb (class I alleles
of Lehmann and Nusslein-Volhard) are embryonic lethals of the
gap type. Gastrulation abnormal; no cephalic fold; cell death
evident at 6 hr later becoming extensive, predominantly in the
neuroectoderm; germ band extension curtailed at 50% of
embryonic length. After germ band shortening embryos lack
thoracic and labial segments; cephalopharyngeal skeleton
present but poorly formed; head involution fails. Seventh and
eighth abdominal segments fused by the deletion of parasegment
13; A1 segment 1.5 times normal width, with eight to ten
deranged denticle rows compared to the normal number of four,
and a widened region of naked cuticle. Filzkorper material
reduced; posterior spiracles fail to evert. Three ventral ganglia absent; gap appears between suboesophogeal region of ventral nerve cord and more posterior trunk ganglia. Extreme
mutants display a reduced number of stripes of ftz expression
at cellular blastoderm; the first stripe is widened and followed by a narrowed gap of nonexpression preceding the second
stripe; the last pair of stripes are fused (Carroll and Scott,
1986, Cell 45: 113-26). Hypomorphic alleles display variably
less severe disruption depending on allele (hbDrv6 = hbb2 =
hbe21 > hbb7 > hbDrv9), the least severe, hbDrv9 lacking only
T2. Class II alleles (Lehmann and Nusslein-Volhard) resemble
the null alleles except that some or all of the prothorax and
A7 are retained. The class III allele retains the labial segment as well. Class IV alleles lack only the mesothoracic
segment. Class V mutants exhibit segment transformations as
well as gaps and are described separately below. Temperature
sensitive period of hbts1 during first four hr of development.
hb/+ offspring produced from homozygous oogenic clones develop
normally; homozygous embryos resulting from such clones
display enhanced zygotic phenotype; gnathal, thoracic, and the
first three abdominal segments replaced by two or three segments of abdominal identity in mirror image relation to the
more posterior abdominal segments; weak alleles without maternal effect; extra doses of hb+ in female without effect on
phenotype of hb offspring. The anterior zone of hb expression
extended posteriorly by six additional cells in the absence of
Kr+; conversely the zone of Kr expression expanded anteriorly
by six to eight cells in hb mutants; posterior zone appears
insensitive to Kr constitution (Jackle, Tautz, Schuh, Seifert,
and Lehmann, 1986, Nature 324: 668-70). hb+ appears to set
the boundaries of Ubx expression (White and Lehmann, 1986,
Cell 47: 311-21); zone of Ubx expression expanded in both
anterior and posterior directions in hb mutant embryos at the
stage of full germ band elongation; segmental disposition of
expression characteristically deranged prior to the advent of
cell death. Although Ubx expression in the ventral nerve chord
at the stage of fully shortened germ band extends from
parasegments 5-13, Ubx protein detected in parasegments 1, 7-12 and 14 in hb12, 3 and 7-14 in hb1, and head to parasegment
1 plus parasegments 7-12 and 14 in hb7 (White and Lehmann).
Phenotypic effects of ftz and hb in double mutants additive in
thorax and anterior abdomen, but more severe than expected in
head and posterior regions.
hb6
hb6/hb6 embryos lack meso- and metathorax, but nine
abdominal segments are formed, the most anterior being T2
transformed into A1 and the next the normal A1.
hb7
Homozygous embryos lack labium and all thoracic segments; head and gnathal segments transformed into posterior
abdominal segments as is A1. Expressed only in homozygotes,
not in hemizygotes; hb7/Df(3R)hb displays class III phenotype.
Lethality of hb7 homozygotes not rescued by Dp(3;Y)P92 which
is able to cover the other alleles; attempts to implicate a
linked lethal mutation negative.
hb11
As in the case of hb7, resembles a class I mutant,
but with transformation of gnathal and first abdominal segments into posterior abdominal segments. Expression in homozygotes more extreme than in hemizygotes.
hbD1: hunchback-Dominant
A gain-of-function mutation; viable both in heterozygous and homozygous condition. Phenotype resembles that of
pbx; insensitive to additional doses of hb+ but suppressed by
extra doses [e. g., five copies of BXC+ (Lewis)]; enhanced in
heterozygous combination with null alleles of ftz.
hbD2
Homozygous lethal; lethal when heterozygous to hb
null alleles (e.g. hb12). Has two dominant phenotypes: 1)
homeotic transformation of parasegment six to parasegment
five, resembling that produced by bxd pbx; 2) a pair-rule
segmentation defect, consisting of partial deletion of even-numbered abdominal segments, principally A2 and A4. Homozygote
shows more extreme expression of both phenotypes; penetrance
and expressivity of first effect enhanced in double heterozygous combination with null alleles of ftz (e.g. hbD2/ftzr14);
second phenotype enhanced by Df(2R)eve, such that only a few
adult escapers of the doubly heterozygous genotype are
observed. Also has a recessive phenotype, revealed either when
homozygous or heterozygous to an hb null allele; deletion of
parasegment 13 and reduction of filzkorper; labial and thoracic segments normal. Thus, affects posterior, but not anterior, domain of hb+ function. Viable in trans to some hypomorphic alleles that do not affect parasegment 13 (e.g. hb6).
| |||
Detailed Mapping Data
| ||||
| FlyBase Computed Cytological Location | ||||
Cytogenetic map Evidence for location 85A5-85A5
Limits computationally determined from genome sequence between P{lacW}l(3)L4740L4740 and P{EP}D1EP473
| ||||
| Experimentally Determined Cytological Location | ||||
Cytogenetic map Notes References 85A3-85B1 (determined by in situ hybridisation)
85A1-85B1 (determined by in situ hybridisation)
85A-85B (determined by in situ hybridisation)
85A3-85A3 (determined by in situ hybridisation)
85A3-85B1 (determined by in situ hybridisation)
| ||||
| Experimentally Determined Recombination Data | ||||
| Location | ||||
| Left of (cM) | ||||
| Right of (cM) | ||||
| Notes | 3-48.3 | |||
| Molecular Map Data | ||||
Gene Order (in direction of increasing cytology)
References Gene Order (overall orientation not stated) References | ||||
Gene Model & Products
| ||||
Please see the
GBrowse view of
Dmel\hb
for information on other features
| ||||
| Comments on Gene Model | ||||
DGC clone LD34229 appears problematic: incomplete CDS | ||||
Transcript Data
| ||||
| Annotated Transcripts | ||||
Name FlyBase ID RefSeq ID Length (nt) Associated CDS (aa) | ||||
| Additional Transcript Data & Comments | ||||
| Reported size (kB) | 3.2, 2.9 (sequence analysis) 3.5, 3.2, 3.0, 2.8, 2.6 (northern blot) 3.2, 2.9 (northern blot) | |||
| Comments | Complete exon/intron structure not defined but these are called "class B"
transcripts by the authors because they initiate at a downstream exon. Complete intron/exon structure not worked out. This is called a "class A"
transcript by authors because it initiates at the 5\\' most leader exon. Sequences upstream of the
start site of transcription for this hb transcript were studied for binding of
bcd protein and used to study transcriptional activation. Five biding sites
were identified and a bcd binding consensus sequence was identified. These
sequences are not responsive in a bcd mutant background. | |||
| External Data | ||||
| Crossreferences | ||||
Polypeptide Data
| ||||
| Annotated Polypeptides | ||||
Name FlyBase ID
Predicted MW (kD)
Length (aa)
Theoretical pI
RefSeq ID
GenBank protein
| ||||
| Additional Polypeptide Data & Comments | ||||
| Reported size (kD) | 758 (aa); 83 (kD predicted) | |||
| Comments | ||||
| External Data | ||||
| Linkouts | PANTHER
- Protein classification by function, families, and pathways
| |||
| Crossreferences | InterPro
domains - A database of protein families, domains, and functional sites
• Zinc finger, C2H2-type (IPR007087)
Zinc finger, C2H2-like (IPR015880)
TRANSFAC
- Eukaryotic transcription factors, their genomic binding sites, and DNA-binding profiles
•
| |||
Sequences Consistent with the Gene Model
| ||||
| DDBJ
/
EMBL / GenBank | DNA sequence Protein sequence Name | |||
| UniProtKB/Swiss-Prot | ||||
| UniProtKB/TrEMBL | ||||
| Maps to | ||||
| Does NOT map to | ||||
| Identified with | ||||
Mapped Features & Mutations
| ||||
Please see
GBrowse
or insertion reports for information on insertions of transgenic
constructs and features not listed here
Type Symbol & Location Additional Notes References aberration junction Df(3R)p25.bk2 3R:4,519,886..4,521,124 comment=The deficiency breakpoint maps to a HindIII-XbaI restriction fragment. evidence=experimental linked_to=HindIII-XbaI_rfrag aberration junction In(3R)hb[bs23].bk2 3R:4,519,886..4,521,124 comment=The inversion breakpoint maps to a HindIII-XbaI restriction fragment. evidence=experimental linked_to=HindIII-XbaI_rfrag aberration junction Df(3R)p[13].bk2 3R:4,527,384..4,527,859 comment=The deficiency breakpoint maps to an EcoRI-EcoRI restriction fragment. evidence=experimental linked_to=EcoRI-EcoRI_rfrag aberration junction In(3R)hb[D2].bk2 3R:4,525,227..4,525,505 comment=The inversion breakpoint maps to a BamHI fragment. evidence=experimental linked_to=BamHI-BamHI_rfrag enhancer hb-enhancer-1 3R:4,526,522..4,527,943 point mutation evidence=experimental na_change=C4519232A pr_change=Y215|hb-PA,Y215|hb-PB reported_na_change=C?A reported_pr_change=Y215@ point mutation hb[12] 3R:4,519,109..4,519,109 comment=TGG to TGA evidence=experimental na_change=G4519109A pr_change=W256|hb-PA,W256|hb-PB reported_na_change=G?A reported_pr_change=W256@ point mutation evidence=experimental na_change=T4519021A pr_change=Y286N|hb-PA,Y286N|hb-PB reported_na_change=T?A reported_pr_change=Y286N point mutation hb[13] 3R:4,518,944..4,518,944 evidence=experimental na_change=G4518944A pr_change=M311I|hb-PA,M311I|hb-PB reported_na_change=G?A reported_pr_change=M311I point mutation reported_na_change=G?A evidence=experimental na_change=G4518756A pr_change=R374H|hb-PA,R374H|hb-PB reported_pr_change=R374H point mutation hb[11] 3R:4,518,448..4,518,448 reported_na_change=C?T evidence=experimental na_change=C4518448T pr_change=Q477|hb-PA,Q477|hb-PB reported_pr_change=Q477@ point mutation reported_na_change=G?A comment=TGG to TGA evidence=experimental na_change=G4518416A pr_change=W487|hb-PA,W487|hb-PB reported_pr_change=W487@ point mutation reported_na_change=C?T evidence=experimental na_change=C4518055T pr_change=Q608|hb-PA,Q608|hb-PB reported_pr_change=Q608@ point mutation reported_na_change=G?A evidence=experimental na_change=G4517748A pr_change=C710Y|hb-PA,C710Y|hb-PB reported_pr_change=C710Y point mutation hb[10] 3R:4,517,665..4,517,665 reported_na_change=T?C evidence=experimental na_change=T4517665C pr_change=C738R|hb-PA,C738R|hb-PB reported_pr_change=C738R protein binding site hb-protein_bind-6 3R:4,524,373..4,524,388 bound_moiety=hb-XP comment=binding site Hb7 evidence=experimental protein binding site hb-protein_bind-7 3R:4,524,272..4,524,287 evidence=experimental comment=binding site Hb6 bound_moiety=hb-XP protein binding site hb-protein_bind-8 3R:4,524,061..4,524,076 bound_moiety=hb-XP comment=binding site Hb5 evidence=experimental protein binding site hb-protein_bind-9 3R:4,523,967..4,523,982 bound_moiety=hb-XP comment=binding site Hb4 evidence=experimental protein binding site hb-protein_bind-10 3R:4,522,755..4,522,770 bound_moiety=hb-XP comment=binding site Hb3 evidence=experimental protein binding site hb-protein_bind-11 3R:4,522,643..4,522,655 bound_moiety=bcd-XP comment=binding site B1 evidence=experimental protein binding site hb-protein_bind-12 3R:4,522,594..4,522,613 bound_moiety=bcd-XP comment=binding site B2 evidence=experimental protein binding site hb-protein_bind-13 3R:4,520,998..4,521,009 bound_moiety=Kr-XP comment=binding site Kr2 evidence=experimental protein binding site hb-protein_bind-14 3R:4,520,981..4,520,996 bound_moiety=hb-XP comment=binding site Hb2 evidence=experimental protein binding site hb-protein_bind-15 3R:4,520,681..4,520,692 bound_moiety=Kr-XP comment=binding site Kr1 evidence=experimental protein binding site hb-protein_bind-16 3R:4,520,590..4,520,604 bound_moiety=bcd-XP comment=binding site A1 evidence=experimental protein binding site hb-protein_bind-17 3R:4,520,497..4,520,512 bound_moiety=hb-XP comment=binding site Hb1 evidence=experimental protein binding site hb-protein_bind-19 3R:4,520,378..4,520,389 bound_moiety=bcd-XP comment=binding site A3 evidence=experimental protein binding site hb-protein_bind-20 3R:4,517,471..4,517,502 protein binding site hb-protein_bind-1 3R:4,527,306..4,527,326 bound_moiety=tll-XP comment=medium strong binding site evidence=experimental protein binding site hb-protein_bind-2 3R:4,527,125..4,527,152 bound_moiety=tll-XP comment=strong binding site evidence=experimental protein binding site hb-protein_bind-3 3R:4,526,813..4,526,831 bound_moiety=tll-XP comment=medium strong binding site evidence=experimental protein binding site hb-protein_bind-4 3R:4,526,654..4,526,687 bound_moiety=tll-XP comment=strong binding site evidence=experimental protein binding site hb-protein_bind-5 3R:4,524,457..4,524,472 bound_moiety=hb-XP comment=binding site Hb8 evidence=experimental protein binding site hb-protein_bind-21 3R:4,527,523..4,527,542 bound_moiety=tll-XP evidence=experimental protein binding site hb-protein_bind-22 3R:4,520,526..4,520,534 evidence=experimental bound_moiety=bcd-XP protein binding site hb-protein_bind-23 3R:4,520,539..4,520,547 bound_moiety=bcd-XP evidence=experimental protein binding site hb-protein_bind-24 3R:4,527,487..4,527,503 bound_moiety=tll-XP evidence=experimental protein binding site hb-protein_bind-25 3R:4,520,452..4,520,465 bound_moiety=bcd-XP evidence=experimental protein binding site hb-protein_bind-26 3R:4,527,002..4,527,022 bound_moiety=tll-XP evidence=experimental protein binding site hb-protein_bind-27 3R:4,520,555..4,520,563 bound_moiety=bcd-XP evidence=experimental protein binding site hb-protein_bind-28 3R:4,527,236..4,527,255 bound_moiety=tll-XP evidence=experimental protein binding site hb-protein_bind-29 3R:4,520,482..4,520,496 bound_moiety=bcd-XP evidence=experimental protein binding site hb-protein_bind-30 3R:4,520,505..4,520,511 bound_moiety=bcd-XP evidence=experimental regulatory region hb-reg_element-3 3R:4,523,042..4,524,208 comment=1.2kb fragment extending from HindIII site to 6bp downstream from splice acceptor site; sufficient to reproduce wild type ovarian pattern of hb expression. evidence=experimental regulatory region hb-reg_element-4 3R:4,519,886..4,520,634 comment=region sufficient for wild type expression of the 2.9kb hb transcript in the anterior domain. evidence=experimental regulatory region hb-reg_element-5 3R:4,517,523..4,517,554 regulatory region hb-reg_element-6 3R:4,517,471..4,517,502 regulatory region hb-reg_element-1 3R:4,526,860..4,527,389 comment=Blastoderm embryo posterior expression element; region drives expression of lacZ in a posterior stripe at 15% egg length and in a posterior cap. evidence=experimental linked_to=EcoRI-RsaI_rfrag regulatory region hb-reg_element-2 3R:4,526,517..4,526,863 comment=Blastoderm embryo posterior expression element; region drives expression of lacZ in a central stripe at 50% egg length and a posterior stripe at 15% egg length. evidence=experimental linked_to=RsaI-SmaI_rfrag rescue fragment hb[KG] 3R:4,515,354..4,527,943 evidence=experimental linked_to=BglII-KpnI_rfrag rescue fragment hb[C20-hb] 3R:4,514,535..4,525,156 comment=partial rescue evidence=experimental linked_to=BamHI-BamHI_rfrag sequence variant hb[15] 3R:4,519,418..4,519,429 comment=A deletion of 10 nucleotides starting in amino acid 150 (exact position unspecified) results in a nonsense frameshift before the first finger domain. evidence=experimental | ||||
External Data
| ||||
| Linkouts | DEDB
- Drosophila exon database: splicing graphs
• | |||
| Crossreferences | EPD
- Eukarytoic Promoter Database, an annotated collection of POL II promoters
| |||
Expression Data
| ||||
| FlyBase-Curated Data | ||||
|
Transcript and Protein data | Please see the FlyBase Gene Expression Report for details of gene expression from the literature. | |||
Summary of Transcript Expression
| ||||
Stage Tissue/Position
Reference
embryonic stage | embryonic cycle 13
embryonic stage | stage 4
embryonic stage | early
embryonic stage | 2-6hr
embryonic stage | embryonic cycle 14
adult stage | female
embryonic stage | early
embryonic stage | stage >8
embryonic central nervous system
embryonic stage | stage 4
oogenesis stage,adult stage | stage S7-S11
nurse cell
embryonic stage | 0-8hr
embryonic stage | stage 4
embryonic stage | embryonic cycle 11-13
embryonic stage | early
embryonic stage | stage 4
embryonic stage | early
embryonic stage | embryonic cycle 14
embryonic stage | stage 4 | ||||
| Marker for | ||||
| Subcellular Localization | ||||
| CV Term | ||||
Summary of Polypeptide Expression
| ||||
Stage Tissue/Position
Reference
embryonic stage | early
embryonic stage | stage 9-11
tritocerebral neuroblast | subset
embryonic stage
neuroblast
embryonic stage | early
embryonic stage | stage 9-11
deuterocerebral neuroblast | subset
embryonic stage | stage 15-17
EW1 neuron
embryonic stage | stage 4
embryonic stage | early
ubiquitous
embryonic stage
neuroblast
embryonic stage | stage 9-11
protocerebral neuroblast | subset
embryonic stage | stage 4
anterior
embryonic stage | early
embryonic stage | early
embryonic stage | early
embryonic stage | early
embryonic stage | stage 15-17
GW neuron
oogenesis stage
embryonic stage | early
ubiquitous | ||||
| Marker for | ||||
| Subcellular Localization | ||||
| CV Term | ||||
External Data & Images
| ||||
| Linkouts | FLIGHT
- Cell culture data for RNAi and other high-throughput technologies
FlyAtlas
- Adult expression by tissue, using Affymetrix Dros2 array
GEO (NCBI)
- Gene expression data: microarray and other high-throughput technologies
FlyExpress
- Embryonic expression images (BDGP data)
| |||
Alleles & Phenotypes
| ||||
Summary of Allele Phenotypes
| ||||
Lethality Allele lethal | | ||||

Stage(s)
1-3
Stage(s)
4-6
Stage(s)
7-8
Stage(s)
9-10
Stage(s)
11-12
Stage(s)
13-16